H-group (homology)
133.1 DBL homology domain (DH-domain)
Ligands and drugs
848
Member domains
79
with ligand contacts (≤ 4 Å)
9.3% of members
75
with DrugDomain annotations
8.8% of members
71
with a DrugBank compound
8.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 133.1 belongs to X-group 133 DH domain-like, which has 4 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03247 | FMN | Flavin mononucleotide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UNX | UNKNOWN ATOM OR ION | 3 |
| LXA | ~{N}-(1~{H}-benzimidazol-2-ylmethyl)-2-methoxy-ethanamide | 2 |
| 60P | 3-methylthiophene-2-carboxylic acid | 1 |
| 9JY | (2S)-3-[(3S)-1-(ethylsulfonyl)piperidin-3-yl]-2-{[3-(4-methylphenyl)imidazo[1,2-a]pyrazin-8-yl]amino}propan-1-ol | 1 |
| 9K1 | (2S)-2-{[3-(4-methylphenyl)imidazo[1,2-a]pyrazin-8-yl]amino}-3-(pyridin-3-yl)propan-1-ol | 1 |
| KLU | (2S)-4-(chloroacetyl)-3,4-dihydro-2H-1,4-benzoxazine-2-carboxamide | 1 |
| LFO | N,1-dimethyl-1H-indole-3-carboxamide | 1 |
| O2A | N-methyl-1H-indole-7-carboxamide | 1 |
| RWS | 1-(5-methyl-1,3,4-thiadiazol-2-yl)piperidine | 1 |
| T7Y | N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide | 1 |
| UWS | 6-methyl-2-[(3-methyl-1,2-oxazol-5-yl)methyl]pyridazin-3(2H)-one | 1 |
| VW7 | N-(8-methyl-1,2,3,4-tetrahydroquinolin-5-yl)acetamide | 1 |
| W0Y | N-methyl-4-sulfamoylbenzamide | 1 |
| WJ7 | 2-bromo-4-fluoro-N,N-dimethylbenzamide | 1 |
| WKY | N-(3-methylpyridin-4-yl)acetamide | 1 |
| YXB | N-[(1H-indol-4-yl)methyl]ethanamine | 1 |
| YXH | 1-(1H-benzimidazol-2-yl)methanamine | 1 |
| YXU | 5-methoxy-1H-pyrrolo[3,2-b]pyridine | 1 |
| YXY | 4,4-difluorocyclohexane-1-carboxamide | 1 |
| YZK | (3M)-3-(2-methyl-1H-imidazol-1-yl)pyridine | 1 |